Sunday, September 22, 2019

8:00 - 8:30: Networking and coffee

8:30 – 8:45: Welcome to Vancouver and introductions – Denise Sharon and Allan O’Bryan (IRLSSG Coordinator)

8:45 – 10:15    Animal models task force - Chairs: Mauro Manconi (Switzerland) and Diego Garcia-Borreguero (Spain)

8:45 – 9:00 Behavioral Animal Models: when phenotype matters and objective markers are missing - Jerry Siegel  (US)

9:00 – 9:15 Critical review of outcome measures of the past models: rationale and need of consensus - Mauro Manconi (Switzerland)

9:15 – 9:30 Expert Consensus Guideline for an animal model of RLS: How to reach a consensus on outcome measures in animal models:     methods and preliminary results - Aaro Salminen (Germany)

9:30 – 9:45 Update on RLS animal models and iron - Richard Allen (USA)

9:45 –10:00 State of the research on animal model KO for BTBD9 - Yuqqing Li  (US)

10:00–10:15 Animals models task force summary and update – Mauro Manconi (Switzerland)   

10:15-10:30      Break

10:30 - 12:00   Moderator:  Cornelius Bachman

10:30 - 10:50   RLS as a disorder of arousal – Richard Allen (USA)

10:50 - 11:10   Update on blood pressure and endothelial dysfunction in RLS – Yves Dauvilliers (France)

11:10 - 11:30   New MRI findings in RLS – Ambra Stefani (Austria)

11:30 - 11:45   A Proteomic and System Biology Approach Reveal Novel Biomarker Signatures for RLS - Raffaele Ferri (Italy)

11:45 - 12:00  The lifespan course of short-interval, periodic and isolated leg movements during sleep – Raffaele Ferri (Italy)

12:00-1:00    Lunch 

Moderator: Rochelle Zak

1:00-2:00      Neurologic co-morbidities of RLS  - Chair: Garima Shukla (Canada)      

1:00 – 1:03 Introduction:  Garima Shukla (Canada)

1:03 -  1:23 Restless legs syndrome and Parkinson's disease - the dopaminergic connection and treatment challenges  - Luigi Ferrini Strambi      (Italy)

1:23 -  1:40 Restless legs syndrome in acute neurological conditions - lessons from stroke and acute neuropathies - Garima Shukla (Canada)

1:40 – 2:00 How RLS contributes to quality of life in Multiple sclerosis – Mauro Manconi (Switzerland)

2:00-3:15       Young investigators (5 presentations 15min each with QA)

3:15-3:30       Break

Moderator: Denise Sharon (USA)

3:30 - 4:50            IRLSSG Projects:

3:30 - 3:45  Diagnostic accuracy of RLS screening tools – Stephany Fulda (Switzerland)

3:45 - 4:00  Update on PLMS scoring program certification – Stephany Fulda (Switzerland)

4:00 - 4:15  National RLS Opioid Registry: 1-2 Year Longitudinal Results-John Winkelman (USA)

4:15 - 4:30    Establishing RSD as a new diagnosis – Lourdes DelRosso (USA)

4:30 - 4:45  Pediatric RLS and GP Task Force update - Arthur Walters (USA)

4:45 – 4:50  Ideas for projects from the attendees?

4:50 - 5:00 Outgoing Chair Summary – Diego Garcia Borreguero (Spain)

5:15 - 6:00            Business meeting